The Experts below are selected from a list of 90 Experts worldwide ranked by ideXlab platform
Luís Costa - One of the best experts on this subject based on the ideXlab platform.
-
the global cancer genomics consortium s third annual symposium from oncogenomics to cancer care
Genes & Cancer, 2014Co-Authors: Radhakrishna M Pillai, Rajendra A. Badwe, Sandra Casimiro, Luís Costa, S Knapp, S. Gupta, Maria CarmofonsecaAbstract:The Global Cancer Genomics Consortium (GCGC) is a Cohesive Network of oncologists, cancer biologists and structural and genomic experts residing in six institutions from Portugal, United Kingdom, Japan, India, and United States. The team is using its combined resources and infrastructures to address carefully selected, shared, burning questions in cancer medicine. The Third Annual Symposium was organized by the Institute of Molecular Medicine, Lisbon Medical School, Lisbon, Portugal, from September 18 to 20, 2013. To highlight the benefits and limitations of recent advances in cancer genomics, the meeting focused on how to better translate our gains in oncogenomics to cancer patients while engaging our younger colleagues in cancer medicine at-large. Over two hundreds participants actively discussed some of the most recent advances in the areas cancer genomics, transcriptomics and cancer system biology and how to best apply such knowledge to cancer therapeutics, biomarkers discovery and drug development, and an essential role played by bio-banking throughout the process. In brief, the GCGC symposium provided a platform for students and translational cancer researchers to share their excitement and worries as we are beginning to translate the gains in oncogenomics to a better cancer patient treatment.
Maria Carmofonseca - One of the best experts on this subject based on the ideXlab platform.
-
the global cancer genomics consortium s third annual symposium from oncogenomics to cancer care
Genes & Cancer, 2014Co-Authors: Radhakrishna M Pillai, Rajendra A. Badwe, Sandra Casimiro, Luís Costa, S Knapp, S. Gupta, Maria CarmofonsecaAbstract:The Global Cancer Genomics Consortium (GCGC) is a Cohesive Network of oncologists, cancer biologists and structural and genomic experts residing in six institutions from Portugal, United Kingdom, Japan, India, and United States. The team is using its combined resources and infrastructures to address carefully selected, shared, burning questions in cancer medicine. The Third Annual Symposium was organized by the Institute of Molecular Medicine, Lisbon Medical School, Lisbon, Portugal, from September 18 to 20, 2013. To highlight the benefits and limitations of recent advances in cancer genomics, the meeting focused on how to better translate our gains in oncogenomics to cancer patients while engaging our younger colleagues in cancer medicine at-large. Over two hundreds participants actively discussed some of the most recent advances in the areas cancer genomics, transcriptomics and cancer system biology and how to best apply such knowledge to cancer therapeutics, biomarkers discovery and drug development, and an essential role played by bio-banking throughout the process. In brief, the GCGC symposium provided a platform for students and translational cancer researchers to share their excitement and worries as we are beginning to translate the gains in oncogenomics to a better cancer patient treatment.
Richard A Benton - One of the best experts on this subject based on the ideXlab platform.
-
corporate governance and nested authority Cohesive Network structure actor driven mechanisms and the balance of power in american corporations
American Journal of Sociology, 2016Co-Authors: Richard A BentonAbstract:Corporate governance describes practices that allocate power and control within public corporations, especially between shareholders, the board of directors, and managers. Shareholder value norms have replaced earlier managerialist governance models. Concurrently, cohesion among the managerial corporate elite has declined, further contributing to a declining managerialist governance consensus. This study considers how governance orientations in publicly held corporations are nested within interfirm Networks. Drawing on prior theory, the author argues that Cohesive substructures among the corporate elite help account for the surprising resilience of managerial control. He finds that more Cohesive subgroups in the board interlock Network have greater managerial control and shows how Cohesive substructures emerge out of local actor-driven mechanisms: (1) directors affiliated with managerialist firms select into dense groups, (2) firms appoint directors from similarly governed firms, and (3) interlocks help s...
Rajendra A. Badwe - One of the best experts on this subject based on the ideXlab platform.
-
the global cancer genomics consortium s third annual symposium from oncogenomics to cancer care
Genes & Cancer, 2014Co-Authors: Radhakrishna M Pillai, Rajendra A. Badwe, Sandra Casimiro, Luís Costa, S Knapp, S. Gupta, Maria CarmofonsecaAbstract:The Global Cancer Genomics Consortium (GCGC) is a Cohesive Network of oncologists, cancer biologists and structural and genomic experts residing in six institutions from Portugal, United Kingdom, Japan, India, and United States. The team is using its combined resources and infrastructures to address carefully selected, shared, burning questions in cancer medicine. The Third Annual Symposium was organized by the Institute of Molecular Medicine, Lisbon Medical School, Lisbon, Portugal, from September 18 to 20, 2013. To highlight the benefits and limitations of recent advances in cancer genomics, the meeting focused on how to better translate our gains in oncogenomics to cancer patients while engaging our younger colleagues in cancer medicine at-large. Over two hundreds participants actively discussed some of the most recent advances in the areas cancer genomics, transcriptomics and cancer system biology and how to best apply such knowledge to cancer therapeutics, biomarkers discovery and drug development, and an essential role played by bio-banking throughout the process. In brief, the GCGC symposium provided a platform for students and translational cancer researchers to share their excitement and worries as we are beginning to translate the gains in oncogenomics to a better cancer patient treatment.
S. Gupta - One of the best experts on this subject based on the ideXlab platform.
-
the global cancer genomics consortium s third annual symposium from oncogenomics to cancer care
Genes & Cancer, 2014Co-Authors: Radhakrishna M Pillai, Rajendra A. Badwe, Sandra Casimiro, Luís Costa, S Knapp, S. Gupta, Maria CarmofonsecaAbstract:The Global Cancer Genomics Consortium (GCGC) is a Cohesive Network of oncologists, cancer biologists and structural and genomic experts residing in six institutions from Portugal, United Kingdom, Japan, India, and United States. The team is using its combined resources and infrastructures to address carefully selected, shared, burning questions in cancer medicine. The Third Annual Symposium was organized by the Institute of Molecular Medicine, Lisbon Medical School, Lisbon, Portugal, from September 18 to 20, 2013. To highlight the benefits and limitations of recent advances in cancer genomics, the meeting focused on how to better translate our gains in oncogenomics to cancer patients while engaging our younger colleagues in cancer medicine at-large. Over two hundreds participants actively discussed some of the most recent advances in the areas cancer genomics, transcriptomics and cancer system biology and how to best apply such knowledge to cancer therapeutics, biomarkers discovery and drug development, and an essential role played by bio-banking throughout the process. In brief, the GCGC symposium provided a platform for students and translational cancer researchers to share their excitement and worries as we are beginning to translate the gains in oncogenomics to a better cancer patient treatment.